Teva Pharmaceutical (TEVA) Finalizes Asset Sale to Clear Allergan Generic Portfolio Purchase

Shares of Teva Pharmaceutical Industries Ltd (TEVA) were trading down -1.61 or -2.99 percent to $52.26 per share in Friday's premarket after news broke late yesterday that the company was finalizing as much as $2 billion in asset sale agreements to clear its acquisition of Allergan Plc's (AGN) generic drug portfolio with U.S. regulators. Teva ... READ MORE Read the rest of Teva Pharmaceutical (TEVA) Finalizes Asset Sale to Clear Allergan Generic Portfolio Purchase at InvestorGuide.com .